
### [Orphanet:314753](http://www.orpha.net/ORDO/Orphanet_314753)
**Label:** Functioning pituitary adenoma

**Subclasses:** [Orphanet:96253](http://www.orpha.net/ORDO/Orphanet_96253) (Cushing disease), [Orphanet:96256](http://www.orpha.net/ORDO/Orphanet_96256) (Somatotropic adenoma), 

**Corr. equiv. classes:** [OMIM:219090](http://purl.obolibrary.org/obo/OMIM_219090), [Orphanet:96253](http://www.orpha.net/ORDO/Orphanet_96253), [Orphanet:96256](http://www.orpha.net/ORDO/Orphanet_96256), [OMIM:102200](http://purl.obolibrary.org/obo/OMIM_102200), 

**Class expressions from DL-Learner:**

- [HP:0040278](http://purl.obolibrary.org/obo/HP_0040278) (Prolactinoma) and [HP:0100829](http://purl.obolibrary.org/obo/HP_0100829) (Galactorrhea) 62.50%
- [HP:0031094](http://purl.obolibrary.org/obo/HP_0031094) (Abnormal breast physiology) and [HP:0040278](http://purl.obolibrary.org/obo/HP_0040278) (Prolactinoma) 62.50%
- [HP:0030972](http://purl.obolibrary.org/obo/HP_0030972) (Abnormal systemic blood pressure) and [HP:0040278](http://purl.obolibrary.org/obo/HP_0040278) (Prolactinoma) 62.50%
- [HP:0030680](http://purl.obolibrary.org/obo/HP_0030680) (Abnormality of cardiovascular system morphology) and [HP:0040278](http://purl.obolibrary.org/obo/HP_0040278) (Prolactinoma) 62.50%
- [HP:0030352](http://purl.obolibrary.org/obo/HP_0030352) (Abnormal serum insulin-like growth factor 1 level) and [HP:0040278](http://purl.obolibrary.org/obo/HP_0040278) (Prolactinoma) 62.50%
- [HP:0030269](http://purl.obolibrary.org/obo/HP_0030269) (Increased serum insulin-like growth factor 1) and [HP:0040278](http://purl.obolibrary.org/obo/HP_0040278) (Prolactinoma) 62.50%
- [HP:0011760](http://purl.obolibrary.org/obo/HP_0011760) (Pituitary growth hormone cell adenoma) and [HP:0040278](http://purl.obolibrary.org/obo/HP_0040278) (Prolactinoma) 62.50%
- [HP:0011025](http://purl.obolibrary.org/obo/HP_0011025) (Abnormality of cardiovascular system physiology) and [HP:0040278](http://purl.obolibrary.org/obo/HP_0040278) (Prolactinoma) 62.50%
- [HP:0008373](http://purl.obolibrary.org/obo/HP_0008373) (Puberty and gonadal disorders) and [HP:0040278](http://purl.obolibrary.org/obo/HP_0040278) (Prolactinoma) 62.50%
- [HP:0001999](http://purl.obolibrary.org/obo/HP_0001999) (Abnormal facial shape) and [HP:0040278](http://purl.obolibrary.org/obo/HP_0040278) (Prolactinoma) 62.50%
- [HP:0001714](http://purl.obolibrary.org/obo/HP_0001714) (Ventricular hypertrophy) and [HP:0040278](http://purl.obolibrary.org/obo/HP_0040278) (Prolactinoma) 62.50%
- [HP:0001713](http://purl.obolibrary.org/obo/HP_0001713) (Abnormal cardiac ventricle morphology) and [HP:0040278](http://purl.obolibrary.org/obo/HP_0040278) (Prolactinoma) 62.50%
- [HP:0001712](http://purl.obolibrary.org/obo/HP_0001712) (Left ventricular hypertrophy) and [HP:0040278](http://purl.obolibrary.org/obo/HP_0040278) (Prolactinoma) 62.50%
- [HP:0001711](http://purl.obolibrary.org/obo/HP_0001711) (Abnormal morphology of the left ventricle) and [HP:0040278](http://purl.obolibrary.org/obo/HP_0040278) (Prolactinoma) 62.50%
- [HP:0001638](http://purl.obolibrary.org/obo/HP_0001638) (Cardiomyopathy) and [HP:0040278](http://purl.obolibrary.org/obo/HP_0040278) (Prolactinoma) 62.50%


